These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2763565)

  • 1. ["Induced detoxification treatment" of opiate dependent patients--a new therapy concept].
    Loimer N; Presslich O; Lenz K; Pfersmann D; Schmid R; Fodor G; Aschauer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):451-4. PubMed ID: 2763565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
    Presslich O; Loimer N; Aschauer G; Fodor G; Pfersmann D; Müller K; Pakesch G; Lieber A
    Psychiatr Prax; 1989 Sep; 16(5):179-81. PubMed ID: 2798589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].
    Hensel M; Volk T; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):261-8. PubMed ID: 10372215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E; Godfroid IO; Guillaume R
    Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
    Yang G; Zhou W; Xu K
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for a general anaesthesia protocol for rapid detoxification from opioids.
    Lorenzi P; Marsili M; Boncinelli S; Fabbri LP; Fontanari P; Zorn AM; Mannaioni PF; Masini E
    Eur J Anaesthesiol; 1999 Oct; 16(10):719-27. PubMed ID: 10583357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and naloxone interactions in opiate-dependent volunteers.
    Mendelson J; Jones RT; Fernandez I; Welm S; Melby AK; Baggott MJ
    Clin Pharmacol Ther; 1996 Jul; 60(1):105-14. PubMed ID: 8689806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
    Arpino PA; Thompson BT
    J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced opiate withdrawal under anaesthesia augments and prolongs the occurrence of withdrawal signs in rats.
    Spanagel R; Kirschke C; Tretter F; Holsboer F
    Drug Alcohol Depend; 1998 Nov; 52(3):251-6. PubMed ID: 9839151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    Adv Alcohol Subst Abuse; 1984; 4(2):89-96. PubMed ID: 6524509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome.
    Bearn J; Bennett J; Martin T; Gossop M; Strang J
    Addict Biol; 2001 Apr; 6(2):147-156. PubMed ID: 11341854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.